This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Medical University of Vienna. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Judith Leitner: Innovator in Pharmaceutical Composition
Introduction
Judith Leitner is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of inflammatory conditions. With a total of 2 patents, her work is recognized for its potential impact on medical treatments.
Latest Patents
One of Judith Leitner's latest patents focuses on the complement split product C4d for the treatment of inflammatory conditions. This invention relates to a pharmaceutical composition that utilizes complement split product C4d to treat various inflammatory conditions, including graft rejection, graft versus host disease, autoimmune diseases, and atopy. The patent also discusses the use of C4d multimers and their applications in medicine. Additionally, it provides details about a protein complex comprising C4d interacting with its ILT4 receptor, which may be utilized in screening methods. The invention also includes antibodies that specifically bind to the C4d multimer or the C4d/ILT4-protein complex.
Career Highlights
Judith Leitner is affiliated with the Medical University of Vienna, where she conducts her research and develops her innovative pharmaceutical compositions. Her work is characterized by a strong focus on addressing complex medical challenges through scientific innovation.
Collaborations
Judith collaborates with esteemed colleagues such as Georg Böhmig and Markus Wahrmann, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Judith Leitner's contributions to the field of pharmaceutical compositions highlight her role as an influential inventor. Her innovative work in treating inflammatory conditions showcases the potential for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
